Nevirapine and Psychiatric decompensation - a phase IV clinical study of FDA data

Summary:

Psychiatric decompensation is reported as a side effect among people who take Nevirapine (nevirapine), especially for people who are male, 50-59 old, also take Lamivudine, and have Depression.

The phase IV clinical study analyzes which people have Psychiatric decompensation when taking Nevirapine. It is created by eHealthMe based on reports of 12,326 people who have side effects when taking Nevirapine from the FDA, and is updated regularly.

What is Nevirapine?

Nevirapine has active ingredients of nevirapine. It is often used in hiv infection. eHealthMe is studying from 12,364 Nevirapine users. Check the latest studies of Nevirapine.

What is Psychiatric decompensation?

Psychiatric decompensation (worsening of symptoms to the state of a serious mental disorder) is found to be associated with 135 drugs and 224 conditions by eHealthMe. Check the latest studies of Psychiatric decompensation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

12,326 people reported to have side effects when taking Nevirapine.
Among them, 19 people (0.15%) have Psychiatric decompensation.

Could Nevirapine cause Psychiatric decompensation?

Among these 19 people:

What is the gender of people who have Psychiatric decompensation when taking Nevirapine? *

female: 0.0 %
male: 100 %

What is the age of people who have Psychiatric decompensation when taking Nevirapine? *

What are other drugs people take besides Nevirapine? *

What are other side effects people have besides Psychiatric decompensation? *

Tearfulness (excess tearing): 4 people, 21.05%
Suicidal Ideation: 4 people, 21.05%
Stress And Anxiety: 4 people, 21.05%
Psychotic Disorder: 4 people, 21.05%
Psychomotor Skills Impaired: 4 people, 21.05%
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 4 people, 21.05%
Motormental Retardation (a slowing-down of thought and a reduction of physical work): 4 people, 21.05%
Mitochondrial Toxicity (a condition in which the mitochondria of a body's cells become damaged or decline significantly in number;): 4 people, 21.05%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 4 people, 21.05%
Eyelid Ptosis (falling of the upper or lower eyelid): 4 people, 21.05%

What are the existing conditions these people have? *

Depression: 19 people, 100.00%
Psychotic Disorder: 4 people, 21.05%
Bipolar Disorder (mood disorder): 4 people, 21.05%

* Approximation only. Some reports may have incomplete information.

Do you take Nevirapine and have Psychiatric decompensation?

- Check whether Psychiatric decompensation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nevirapine:

Nevirapine (12,364 reports)

Browse all side effects of Nevirapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psychiatric decompensation:

Psychiatric decompensation (135 drugs)

Browse all the conditions that are associated with Psychiatric decompensation:

Psychiatric decompensation (224 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nevirapine (the active ingredients of Nevirapine) and Nevirapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.